Abstract
Genome sequences from the pufferfishes Takifugu rubripes (Fugu) and Tetraodon nigroviridis, the zebrafish Danio rerio and the medaka Oryzias latipes together with genomic data from various other fish species have opened an important era of comparative genomics shedding a new light on the structure and evolution of vertebrate genomes. For instance, comparative analysis of fish genomes has revealed that the ancestral bony vertebrate genome was composed of 12 chromosomes, has confirmed the occurrence of at least one event of genome duplication in the early history of vertebrates and has allowed the identification of conserved regulatory and coding sequences in the human genome. Importantly, major differences have been observed between teleost fish and mammalian genomes. There is now convincing evidence that all teleosts are derived from a common tetraploid fish ancestor. This tetraploidization event arose about 320-350 million years ago in the ray-finned fish lineage, followed by rediploidization and retention of hundreds of duplicate pairs. Divergent evolution of the resulting duplicates has been proposed to be involved in the species richness observed in teleost fishes. Fish genomes also contain many more families of transposable elements than mammals and birds. Finally, while the mammalian and bird lineages possess major sex determination systems with sex chromosomes conserved in very divergent species, fishes have very frequently switched between sex determination mechanisms and repeatedly created novel sex chromosomes during evolution. Hence, teleost fishes display a high level of genomic plasticity, which might be related to the astonishing biodiversity observed in these animals.
Keywords: Fish, teleost, vertebrate, evolution, genome, duplication, sex chromosome, retroelement
Current Genomics
Title: Fish Genomes, Comparative Genomics and Vertebrate Evolution
Volume: 7 Issue: 1
Author(s): A. Froschauer, I. Braasch and J.- N. Volff
Affiliation:
Keywords: Fish, teleost, vertebrate, evolution, genome, duplication, sex chromosome, retroelement
Abstract: Genome sequences from the pufferfishes Takifugu rubripes (Fugu) and Tetraodon nigroviridis, the zebrafish Danio rerio and the medaka Oryzias latipes together with genomic data from various other fish species have opened an important era of comparative genomics shedding a new light on the structure and evolution of vertebrate genomes. For instance, comparative analysis of fish genomes has revealed that the ancestral bony vertebrate genome was composed of 12 chromosomes, has confirmed the occurrence of at least one event of genome duplication in the early history of vertebrates and has allowed the identification of conserved regulatory and coding sequences in the human genome. Importantly, major differences have been observed between teleost fish and mammalian genomes. There is now convincing evidence that all teleosts are derived from a common tetraploid fish ancestor. This tetraploidization event arose about 320-350 million years ago in the ray-finned fish lineage, followed by rediploidization and retention of hundreds of duplicate pairs. Divergent evolution of the resulting duplicates has been proposed to be involved in the species richness observed in teleost fishes. Fish genomes also contain many more families of transposable elements than mammals and birds. Finally, while the mammalian and bird lineages possess major sex determination systems with sex chromosomes conserved in very divergent species, fishes have very frequently switched between sex determination mechanisms and repeatedly created novel sex chromosomes during evolution. Hence, teleost fishes display a high level of genomic plasticity, which might be related to the astonishing biodiversity observed in these animals.
Export Options
About this article
Cite this article as:
Froschauer A., Braasch I. and Volff N. J.-, Fish Genomes, Comparative Genomics and Vertebrate Evolution, Current Genomics 2006; 7 (1) . https://dx.doi.org/10.2174/138920206776389766
DOI https://dx.doi.org/10.2174/138920206776389766 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus
Current Pharmaceutical Design Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway
Current Cancer Drug Targets Phosphonomethoxyalkyl Analogs of Nucleotides
Current Pharmaceutical Design Targeting the JAK/STAT Signaling Pathway for Breast Cancer
Current Medicinal Chemistry In Vitro, In Vivo and In Silico Analysis of the Anticancer and Estrogen-like Activity of Guava Leaf Extracts
Current Medicinal Chemistry Lipid Matrix Nanoparticles: Pharmacokinetics and Biopharmaceutics
Current Nanoscience The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Activated Lymph Nodes Recruit Blood Borne NK Cells and Effector T Cells:Implications for Adaptive T Cell Responses
Current Immunology Reviews (Discontinued) Insights into Ecto-5’-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study
Current Medicinal Chemistry Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial
Current Pharmaceutical Design Structural, Functional and Therapeutic Aspects of Snake Venom Metalloproteinases
Mini-Reviews in Organic Chemistry Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets Target Therapies in Pancreatic Carcinoma
Current Medicinal Chemistry Innate Immune Surveillance in the Central Nervous System Following Legionella pneumophila Infection
CNS & Neurological Disorders - Drug Targets PROGRAMMED Cell Clearance: Molecular Mechanisms and Role in Autoimmune Disease, Chronic Inflammation, and Anti-Cancer Immune Responses
Current Immunology Reviews (Discontinued) bHLH Transcription Factors Inhibitors for Cancer Therapy: General Features for In Silico Drug Design
Current Medicinal Chemistry Microsphere Based Improved Sunscreen Formulation of Ethylhexyl Methoxycinnamate
Current Drug Delivery Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain
Current Pharmaceutical Design From ONYX-015 to Armed Vaccinia Viruses: The Education and Evolution of Oncolytic Virus Development
Current Cancer Drug Targets Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug Targets